RNF40 inhibitors constitute a unique category of chemical compounds that have shown promise in modulating the activity of the RNF40 enzyme. RNF40, a member of the E3 ubiquitin ligase family, is responsible for catalyzing monoubiquitination, a specific post-translational modification that involves the addition of a single ubiquitin molecule to target proteins. This modification has been implicated in diverse cellular processes, including but not limited to transcriptional regulation, DNA repair, and chromatin remodeling. By inhibiting the enzymatic function of RNF40, these compounds offer a valuable means to investigate the intricate network of cellular pathways influenced by monoubiquitination. The mechanism of action of RNF40 inhibitors involves disrupting the enzymatic activity of RNF40, leading to altered ubiquitination patterns on target proteins. This, in turn, can impact the stability, localization, and interactions of these proteins within the cellular environment.
As a result, RNF40 inhibitors provide researchers with a potent tool to probe the functional consequences of modulating the monoubiquitination process. This can aid in unraveling the underlying molecular mechanisms governing key cellular events and pathways. Due to the broad involvement of monoubiquitination in various biological processes, RNF40 inhibitors have attracted attention as potential research probes. By selectively targeting RNF40 without significantly affecting other cellular processes, these inhibitors allow for controlled investigations into the roles of monoubiquitination in specific contexts. This chemical class offers a versatile platform for studying cellular dynamics, protein function, and regulatory mechanisms, ultimately contributing to a deeper understanding of cell biology. Researchers are actively exploring the effects of RNF40 inhibitors in various cellular models to uncover insights into the functional consequences of disrupting the monoubiquitination pathway. While implications of these inhibitors are beyond the scope of this description, their potential impact on fundamental cellular processes underscores their significance as valuable tools in the realm of scientific exploration.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NSC697923 | 343351-67-7 | sc-391107 sc-391107A | 1 mg 5 mg | $15.00 $52.00 | 3 | |
Identified as an inhibitor of RNF40. Promotes apoptosis in cells by affecting protein stability. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Initially known as an inhibitor of the E1 ubiquitin-activating enzyme, it also inhibits RNF40, leading to substrate accumulation and cellular effects. | ||||||
Pyrvinium Pamoate | 3546-41-6 | sc-476920A sc-476920 | 250 mg 500 mg | $228.00 $422.00 | ||
Inhibits RNF40-mediated ubiquitination. Shows potential in inhibiting cell growth by altering gene expression. | ||||||
MS417 | 916489-36-6 | sc-507505 | 5 mg | $228.00 | ||
Selective RNF40 inhibitor. Affects gene expression related to tumor progression and metastasis. | ||||||
4-[(1E)-2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-2-pyridinylbenzenesulfonamide | 1395084-25-9 | sc-480120 | 5 mg | $300.00 | ||
Similar to MS417, it influences gene expression and cellular processes relevant | ||||||
AMI-1, sodium salt | 20324-87-2 | sc-205928 sc-205928A | 5 mg 25 mg | $114.00 $398.00 | 2 | |
Known for inhibiting protein arginine methyltransferases (PRMTs), also affects RNF40 activity and histone ubiquitination. | ||||||